New eye implant could rival standard glaucoma surgery

NCT ID NCT07496957

Recruiting now Disease control Sponsor: Medical University of Bialystok Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a tiny drainage device called the Preserflo MicroShunt can lower eye pressure as well as the standard trabeculectomy surgery in adults with open-angle glaucoma. One hundred participants will be randomly assigned to receive one of the two procedures and will be followed for 12 months. The goal is to see if the MicroShunt is a safe and effective alternative that may be less invasive.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Preserflo MicroShunt (a tiny drainage device) and trabeculectomy (a surgical procedure)
What this could lead to: If the Preserflo MicroShunt works as well as trabeculectomy, it could offer a less invasive surgical option for controlling eye pressure in glaucoma patients.
What could go wrong: This is a relatively small, early-stage comparison study (100 participants) and the device may not prove as effective or safe as the standard surgery. Complications like scarring or infection are possible with both procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA 1, OPEN ANGLE, D (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exfoliation syndrome glaucoma 1, open angle, l low tension glaucoma open-angle glaucoma pigment dispersion syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA 1, OPEN ANGLE, D (DISORDER)

Contacts and locations

Locations

Medical University of Bialystok
RECRUITING

Bialystok, Polska, 15-089, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.